BlackRock Fund Advisors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.69M Buy
247,066
+43,155
+21% +$828K ﹤0.01% 2962
2016
Q3
$4.52M Buy
203,911
+8,393
+4% +$158K ﹤0.01% 2890
2016
Q2
$3.57M Buy
195,518
+55,996
+40% +$964K ﹤0.01% 2995
2016
Q1
$2.54M Sell
139,522
-7,770
-5% -$126K ﹤0.01% 3006
2015
Q4
$2.48M Buy
147,292
+4,011
+3% +$68.1K ﹤0.01% 3097
2015
Q3
$2.58M Sell
143,281
-1,475
-1% -$32.9K ﹤0.01% 3061
2015
Q2
$3.75M Sell
144,756
-597
-0.4% -$15.1K ﹤0.01% 3039
2015
Q1
$3.18M Buy
+145,353
New +$3.14M ﹤0.01% 3026

Other funds holding ENTL

BlackRock Fund Advisors's ENTL Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Entellus Medical, Inc. Common Stock (ENTL) stake by 21% in Q4 2016, buying an estimated $828K and bringing the position to 247,066 shares worth $4.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2962.

BlackRock Fund Advisors first reported a position in ENTL in Q1 2015 and has held it in 8 quarters since. 63 funds tracked by Wall St. Rank hold ENTL as of Q4 2016.

  • BlackRock Fund Advisors held 247,066 shares of Entellus Medical, Inc. Common Stock worth $4.69M as of Q4 2016.
  • BlackRock Fund Advisors bought 43,155 Entellus Medical, Inc. Common Stock shares in Q4 2016, an estimated $828K.
  • Entellus Medical, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2962 holding.
  • BlackRock Fund Advisors first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and has held it in 8 quarters since.
  • 63 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.